Autor segons l'article: Fernández-Cao JC, Arija V, Aranda N, Basora J, Diez-Espino J, Estruch R, Fitó M, Corella D, Salas-Salvadó J
Departament: Bioquímica i Biotecnologia Ciències Mèdiques Bàsiques Medicina i Cirurgia Ciències Mèdiques Bàsiques
Autor/s de la URV: Aranda Pons, Núria / Arija Val, Maria Victoria / Basora Gallisa, Josep / Salas Salvadó, Jorge
Paraules clau: Type 2 diabetes mellitus Type 2 diabetes Soluble transferrin receptor Predimed Obesity Nested case–control Nested case-control Body iron stores predimed
Resum: Studies evaluating the relationship between soluble transferrin receptor (sTfR), a biomarker inversely related to body iron stores, and risk of type 2 diabetes mellitus (T2DM) are scarce and inconclusive. Furthermore, sTfR concentrations have been observed to be significantly higher in obese than in nonobese individuals. Therefore, the aim of this study was to assess the relationship between sTfR and the risk of T2DM in obese and nonobese subjects.A nested case-control study of 153 cases of newly diagnosed diabetic subjects, 73 obese and 80 nonobese, and 306 individually matched controls, 138 obese and 166 nonobese, who did not develop T2DM for a median 6-year follow-up (interquartile range: 3·9-6·5) was conducted using data from the PREvention with MEDiterranean Diet (PREDIMED) cohort (http://www.controlled-trials.com/ISRCTN35739639). Cases and controls were matched for age (? 67 vs. > 67 years), gender, dietary intervention group and BMI (? 27 vs. > 27 kg/m2 ).Waist circumference is the main determinant of sTfR concentrations in the whole sample (? = 0·476, P < 0·001), in the obese (? = 0·802, P < 0·001) and the nonobese (? = 0·455, P = 0·003). Furthermore, sTfR is directly associated with the risk of T2DM in obese individuals (OR = 2·79; 95% CI: 1·35-5·77, P = 0·005) and inversely associated in nonobese individuals (OR = 0·40; 95% CI: 0·20-0·79, P = 0·015).The association between sTfR levels and risk of T2DM in a population at high cardiovascular risk depend on the presence or absence of obesity. While in nonobese subjects elevated sTfR levels are associated with a decreased risk of developing T2DM, in obese subjects the risk increases. This suggests that obesity alters the relationship between sTfR and T2DM incidence.© 2017 Stichting European Society for Clinical Investigation Journal Foundation.
Àrees temàtiques: Saúde coletiva Odontología Nutrição Medicine, research & experimental Medicine, general & internal Medicine (miscellaneous) Medicina ii Medicina i Interdisciplinar General medicine Farmacia Educação física Clinical biochemistry Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Biotecnología Biochemistry
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 00142972
Adreça de correu electrònic de l'autor: josep.basora@urv.cat nuria.aranda@urv.cat josep.basora@urv.cat jordi.salas@urv.cat victoria.arija@urv.cat
Identificador de l'autor: 0000-0001-9708-747X 0000-0003-2700-7459 0000-0002-1758-0975
Data d'alta del registre: 2024-09-07
Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: European Journal Of Clinical Investigation. 47 (3): 221-230
Referència de l'ítem segons les normes APA: Fernández-Cao JC, Arija V, Aranda N, Basora J, Diez-Espino J, Estruch R, Fitó M, Corella D, Salas-Salvadó J (2017). Soluble transferrin receptor and risk of type 2 diabetes in the obese and non-obese.. European Journal Of Clinical Investigation, 47(3), 221-230. DOI: 10.1111/eci.12725
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2017
Tipus de publicació: Journal Publications
Repositori URV